Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF2B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DNASE1L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPON1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NDUFS7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WDR45 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PIGT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRUNE2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCLK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYDGF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KCNA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TAGLN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DLL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLN3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
VRK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APOBEC3C - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATP6V0D1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C11orf80 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NDST2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GART - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on